The Science of Healing Your Body with Your Mind | Dr Joe Dispenza

What It Covers

Dr. Joe Dispenza joins Lewis Howes to explain the neuroscience behind meditation-driven healing, drawing on fMRI studies, gene expression research, and endogenous opioid data. The conversation covers how 95% of behavior runs on subconscious programming, why the body resists change, and how seven-day immersive meditation events produce measurable biological transformation across 63 chronic health conditions.

Key Questions Answered

• •The 95/5 Subconscious Split: By adulthood, only 5% of daily behavior is consciously directed; the remaining 95% runs on subconscious programs built through repeated thoughts, emotions, and habits. Positive affirmations fail when the body is conditioned to a contradictory emotional state. To reprogram, brainwaves must slow enough to bypass the analytical mind and access the subconscious operating system directly — the mechanism meditation specifically targets.
• •Body-as-Mind Conditioning: When a person repeatedly recalls a painful memory, the body cannot distinguish between the real past event and the mentally replayed version, releasing identical stress chemistry each time. Over time, the body becomes conditioned to that emotional state and actively resists change because the unknown feels biologically dangerous. Breaking this loop requires catching the body mid-reaction and consciously returning attention to the present moment.
• •The Push-Past-Done Principle: UC San Diego fMRI research on seven-day meditators shows the brain changes most dramatically at the exact moment a person pushes past the point where they feel certain they are done. Continuing beyond that threshold stretches the nervous system into unfamiliar territory without negative consequence, which gradually trains the body to tolerate and then relax into the unknown — the prerequisite state for neurological and biological change.
• •Internal Pharmacy Data: Across seven-day meditation events, 100% of measured participants produced elevated endogenous opioids, including dynorphin at concentrations so high samples required dilution before measurement. This compares to a 25% efficacy benchmark for top pharmaceutical pain trials. Across 63 different chronic conditions including cancer, MS, PTSD, and Parkinson's, participants reported pain reduction and increased energy independent of their specific diagnosis after the same single intervention.
• •Default Mode Network Shutdown: Seven-day meditators in the UC San Diego fMRI study showed default mode network suppression comparable to psilocybin use — without any substance. The default mode network, the brain's prediction and anticipation system, consumes the majority of brain energy. When it quiets, freed energy redirects to cellular repair and growth. Participants also showed increased brain volume, new neuron formation, and elevated neurotrophic factors in blood samples post-retreat.
• •Gene Regulation by Intention: In controlled studies, participants with no scientific background were placed in a coherent mental-emotional state and given only the name and image of a specific protein-producing gene. With no knowledge of amino acid sequences or molecular structure, 100% of participants in the first study and 95% in the second successfully regulated the target gene through intention alone. This suggests focused mental states can serve as biological signals at the genetic level.
• •Remote Coherence Healing and PTSD: In a three-month study, participants clinically diagnosed with PTSD received no medication, therapy, or lifestyle intervention. Groups of 70 to 100 remote healers, scattered globally, focused coherent intention on participant photos simultaneously. Nine out of ten PTSD participants no longer met clinical diagnostic criteria at study's end — a success rate exceeding any current pharmaceutical benchmark for the condition, suggesting non-local field effects produce measurable physiological outcomes.